These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9241676)
21. Thalidomide ban to be lifted in the US. Rutter T BMJ; 1997 Sep; 315(7110):699. PubMed ID: 9314750 [No Abstract] [Full Text] [Related]
22. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of butyl benzyl phthalate. Kavlock R; Boekelheide K; Chapin R; Cunningham M; Faustman E; Foster P; Golub M; Henderson R; Hinberg I; Little R; Seed J; Shea K; Tabacova S; Tyl R; Williams P; Zacharewski T Reprod Toxicol; 2002; 16(5):453-87. PubMed ID: 12406492 [No Abstract] [Full Text] [Related]
23. Evolving knowledge of the teratogenicity of medications in human pregnancy. Adam MP; Polifka JE; Friedman JM Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440 [TBL] [Abstract][Full Text] [Related]
26. Some experiences relating to food safety. Mrak EM Environ Qual Saf; 1976; 5():197-207. PubMed ID: 829667 [No Abstract] [Full Text] [Related]
27. Natural teratogens in human foods and the chemistry of embryology. McLaughlin JL Prog Clin Biol Res; 1985; 163C():389-94. PubMed ID: 3991648 [No Abstract] [Full Text] [Related]
28. Vitamin A teratogenicity and risk assessment in the macaque retinoid model. Tzimas G; Nau H Reprod Toxicol; 2001; 15(4):445-7. PubMed ID: 11515502 [No Abstract] [Full Text] [Related]
29. Reiterations: birth defects caused by isotretinoin and smoking and tobacco use as addicting. Zellmer WA Am J Hosp Pharm; 1988 Jun; 45(6):1295. PubMed ID: 3166340 [No Abstract] [Full Text] [Related]
31. Potential subversion of pregnancy prevention program in the managed care setting. Wilkin JK Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846 [No Abstract] [Full Text] [Related]
32. Evaluation of maternal and developmental toxicity. Proceedings of the consensus workshop. Rockville, Maryland, May 12-14, 1986. Teratog Carcinog Mutagen; 1987; 7(3):201-338. PubMed ID: 2888200 [No Abstract] [Full Text] [Related]
33. Inadequate response from the FDA. Scialli AR Reprod Toxicol; 1992; 6(6):465-6. PubMed ID: 1288756 [No Abstract] [Full Text] [Related]
34. Bendectin, science, and the law. Scialli AR Reprod Toxicol; 1989; 3(3):157-8. PubMed ID: 2520517 [No Abstract] [Full Text] [Related]
35. FDA, Roche to implement new dispensing procedures for isotretinoin. Young D Am J Health Syst Pharm; 2001 Dec; 58(24):2359-60. PubMed ID: 11794946 [No Abstract] [Full Text] [Related]
36. Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials. Kuehn BM JAMA; 2010 Nov; 304(19):2109-10, 2112. PubMed ID: 21081717 [No Abstract] [Full Text] [Related]
37. Exposures in pregnancy that are harmful to the fetus i.e. human teratogens. Holmes LB Pediatr Res; 1999 Feb; 45(2):286-7. PubMed ID: 10022604 [No Abstract] [Full Text] [Related]
38. Evaluation of health aspects of GRAS food ingredients: lessons learned and questions unanswered. Siu RG; Borzelleca JF; Carr CJ; Day HG; Fomon SJ; Irving GW; La Du BN; McCoy JR; Miller SA; Plaa GL; Shimkin MB; Wood JL Fed Proc; 1977 Oct; 36(11):2519-62. PubMed ID: 332533 [No Abstract] [Full Text] [Related]
39. Sexism in toxicology. Forest W Reprod Toxicol; 1990; 4(2):159. PubMed ID: 2136030 [No Abstract] [Full Text] [Related]
40. Teratogenicity of recently introduced medications in human pregnancy. Lo WY; Friedman JM Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]